- Fund Type: SICAV
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: Global
BlackRock Global Funds - World Healthscience Fund
+ Add to WatchlistMERHLTA:LX
23.18 USD 0.08 0.35%As of 00:59:30 ET on 06/18/2013.
Snapshot for BlackRock Global Funds - World Healthscience Fund (MERHLTA)
| Year To Date: | +21.84% | 3-Month: | +7.29% | 3-Year: | +16.83% | 52-Week Range: | 17.31 - 23.72 |
|---|---|---|---|---|---|---|---|
| 1-Month: | -0.94% | 1-Year: | +32.45% | 5-Year: | +10.23% | Beta vs NDWUHC: | 1.05 |
Fund Profile & Information for MERHLTA
BlackRock Global Funds - World Healthscience Fund is an open-end Fund incorporated in Luxembourg. The Fund's objective is to maximize growth in United States dollars. The Fund invests globally in equities of companies with substantial interests in healthcare, pharmaceuticals and medical technology and supplies.
| Inception Date: | 04-06-2001 | Telephone: | 352-34-20-101 |
|---|---|---|---|
| Managers: | THOMAS P CALLAN / H ERIN XIE | ||
| Web Site: | www.blackrockinternational.com | ||
Fundamentals for MERHLTA
| NAV | (on 2013-06-19) 23.18 |
|---|---|
| Assets (M) | (on 2013-05-31) 976.40 |
| Fund Leveraged | N |
| Minimum Investment | 5,000.00 |
| Minimum Subsequent Investment | 1,000.00 |
Dividends for MERHLTA
No dividends reported
Fees & Expenses for MERHLTA
| Front Load | 5.00 |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 1.50 |
| Redemption Fee | 0.00 |
| 12b1 Fee | - |
| Expense Ratio | 1.84 |
Top Fund Holdings for MERHLTA
Filing Date: 03/28/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Gilead Sciences Inc | 700,386 | 34,269,887 | 4.518% |
| Novartis AG | 474,500 | 33,798,009 | 4.456% |
| Johnson & Johnson | 412,500 | 33,631,125 | 4.434% |
| Roche Holding AG | 129,700 | 30,269,497 | 3.991% |
| Celgene Corp | 254,690 | 29,521,118 | 3.892% |
| Amgen Inc | 262,700 | 26,929,377 | 3.550% |
| Bristol-Myers Squibb Co | 611,900 | 25,204,161 | 3.323% |
| Eli Lilly & Co | 398,500 | 22,630,815 | 2.984% |
| Sanofi | 221,800 | 22,577,157 | 2.976% |
| AbbVie Inc | 486,000 | 19,819,080 | 2.613% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page